Choucha Anis, Boissonneau Sebastien, Beucler Nathan, Graillon Thomas, Ranque Stephane, Bruder Nicolas, Fuentes Stephane, Velly Lionel, Dufour Henry
Department of Neurosurgery, Aix Marseille University, APHM, UH Timone, Marseille, France -
Department of Neurosurgery, Aix Marseille University, APHM, UH Timone, Marseille, France.
J Neurosurg Sci. 2023 Apr;67(2):248-256. doi: 10.23736/S0390-5616.21.05397-2. Epub 2021 Aug 3.
The benefits of decompressive craniectomy (DC) have been demonstrated in malignant ischemic stroke and traumatic brain injuries with refractory intracranial hypertension (ICH) by randomized controlled trials. Some reports advocate the potential of DC in the context of ICH due to meningoencephalitis (ME) with focal cerebral edema, but its interest remains controversial especially when there is diffuse cerebral edema. The aim of this study is to assess the benefits of DC in meningoencephalitis with malignant cerebral edema whether it is focal or diffuse. We report two cases successfully treated in our institute, plus we conducted a systematic literature review focused on cases of DC in ME in compliance with Prisma guidelines. The first patient is a 36-year-old woman who suffered from fulminant pneumococcal meningoencephalitis (ME) with refractory ICH following a transsphenoidal removal of pituitary adenoma. The second patient is a 20-year-old man suffering from neuro-meningeal cryptococcosis with refractory ICH. In both cases DC led to major clinical improvement with a GOS-E 8 at one year. These results are consistent with the literature review which reports a favorable outcome in 85% of cases. DC appears to be a promising therapeutic option in cases of ME with refractory ICH. Thus, reliable criteria will have to be defined to guide us in our practice in emergency cases where DC has not been part of the therapeutic arsenal yet.
减压性颅骨切除术(DC)的益处已在恶性缺血性中风和伴有难治性颅内高压(ICH)的创伤性脑损伤中通过随机对照试验得到证实。一些报告主张DC在因脑膜脑炎(ME)伴局灶性脑水肿导致的ICH情况下具有潜在作用,但其价值仍存在争议,尤其是当存在弥漫性脑水肿时。本研究的目的是评估DC在伴有恶性脑水肿的脑膜脑炎中的益处,无论脑水肿是局灶性还是弥漫性。我们报告了在我院成功治疗的两例病例,此外,我们按照Prisma指南对有关脑膜脑炎中DC病例的文献进行了系统综述。第一例患者是一名36岁女性,在经蝶窦切除垂体腺瘤后患上暴发性肺炎球菌性脑膜脑炎(ME)并伴有难治性ICH。第二例患者是一名20岁男性,患有神经脑膜隐球菌病并伴有难治性ICH。在这两例病例中,DC均带来了显著的临床改善,一年时的扩展格拉斯哥预后量表(GOS-E)评分为8分。这些结果与文献综述一致,文献综述报告85%的病例预后良好。DC似乎是伴有难治性ICH的脑膜脑炎病例中一种有前景的治疗选择。因此,必须定义可靠的标准,以便在DC尚未成为治疗手段的急诊病例中指导我们的实践。